+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Severe hypoglycemia in a patient with type 2 diabetes mellitus on metformin monotherapy



Severe hypoglycemia in a patient with type 2 diabetes mellitus on metformin monotherapy



Journal of the Association of Physicians of India 55: 458-459




(PDF emailed within 1 workday: $29.90)

Accession: 055739587

Download citation: RISBibTeXText

PMID: 17882769


Related references

Hypoglycemia Incidence Rates and Associated Health Care Costs in Patients with Type 2 Diabetes Mellitus Treated with Second-Line Linagliptin or Sulfonylurea After Metformin Monotherapy. Journal of Managed Care and Specialty Pharmacy 22(5): 483-492, 2017

Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases. Medicine 93(23): E148, 2015

Gatifloxacin-induced severe hypoglycemia in a patient with type 2 diabetes mellitus. Journal of the Association of Physicians of India 54: 953-954, 2007

The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 13(7): 644-652, 2011

Evaluation of efficacy and tolerability of glimepiride and metformin combination: a multicentric study in patients with type-2 diabetes mellitus, uncontrolled on monotherapy with sulfonylurea or metformin. American Journal of Therapeutics 20(1): 41-47, 2013

Evaluation of efficacy and tolerability of gliclazide and metformin combination: a multicentric study in patients with type 2 diabetes mellitus uncontrolled on monotherapy with sulfonylurea or metformin. American Journal of Therapeutics 17(6): 559-565, 2011

Metformin monotherapy for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2005(3): Cd002966, 2005

Treatment Compliance with Fixed-Dose Combination of Vildagliptin/Metformin in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin Monotherapy: A 24-Week Observational Study. International Journal of Endocrinology 2015: 251485, 2015

Weight loss, arterial hypotension and severe hypoglycemia in a 29-year-old patient with type 1 diabetes mellitus. Der Internist 43(3): 410-413, 2002

Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients. European Journal of Endocrinology 175(6): 531-540, 2016

Severe lactic acidosis and acute pancreatitis associated with cimetidine in a patient with type 2 diabetes mellitus taking metformin. Internal Medicine 52(19): 2245-2248, 2014

Metformin monotherapy in children and adolescents with type 2 diabetes mellitus in Japan. Diabetology International 10(1): 51-57, 2019

Perioperative management in a patient with type 1 diabetes mellitus who presented severe hypoglycemia during dental implant surgery: a case report. Bmc Oral Health 18(1): 204-204, 2018

Monotherapy with metformin or glimepiride and changes in serum sialic acid in type 2 diabetes mellitus. The British Journal of Diabetes & Vascular Disease 11(3): 137-140, 2011

Comparative evaluation of efficacy and safety of combination of metformin-vidagliptin versus metfromin-glimepiride in most frequently used doses in patients of type 2 diabetes mellitus with inadequately controlled metformin monotherapy-A randomised open label study. Perspectives in Clinical Research 6(3): 163-168, 2015